Interestingly, IDH2 protein also showed differential expression in the MPN-AITL patients, which contributes to the growing evidence of this protein’s role in both myeloid neoplasia and AITL. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.